Literature DB >> 25826002

Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage.

Suzan Tug1, Susanne Helmig1, Eva Ricarda Deichmann1, Anna Schmeier-Jürchott2, Eva Wagner2, Tim Zimmermann3, Markus Radsak2, Mauro Giacca4, Perikles Simon1.   

Abstract

The role of cell free DNA (cfDNA) has been intensively discussed under various pathological conditions and after acute bouts of exercise. To date, there is still no conclusive evidence concerning the cellular origin of cfDNA and the entire mechanism leading to elevated cfDNA concentrations in human plasma and serum. Here, we investigated the cellular origin of cfDNA in sex-mismatched haematopoietic stem cell transplantation (HSCT) and liver transplantation (LT) patients by determining the relative proportion of Y-chromosomal to total nuclear cfDNA. Total nuclear cfDNA and Y-chromosomal cfDNA concentrations were determined in blood plasma before and after an incremental exercise test via quantitative real-time PCR (qPCR). Female HSCT patients showed high proportions of Y-chromosomal cfDNA. Both total nuclear and Y-chromosomal cfDNA increased significantly and in a highly correlated fashion due to exercise. In male HSCT patients with female donors less than 10% of the cfDNA was of Y-chromosomal origin at any point in time and even though the total amount of cfDNA increased during exercise, no increases in Y-chromosomal DNA could be detected. The percentage of Y-chromosomal cfDNA in female LT patients with male donors was very low and levels remained unchanged during exercise. This indicates that cells not derived from the bone marrow, in this case transplanted liver cells, represented only a minor fraction of cfDNA in blood plasma and were not released during acute physical exercise. Even though many physiological conditions may be altered in transplant patients versus healthy people, our results strongly suggest that cells from the haematopoietic lineage are the main source of cfDNA released during acute bouts of exercise.
Copyright © 2015 International Society of Exercise and Immunology. All rights reserved.

Entities:  

Keywords:  Y-chromosomal PCR; cell free DNA; exercise; graft rejection; sex-mismatched transplantation

Mesh:

Substances:

Year:  2015        PMID: 25826002

Source DB:  PubMed          Journal:  Exerc Immunol Rev        ISSN: 1077-5552            Impact factor:   6.308


  31 in total

Review 1.  Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.

Authors:  Michael Oellerich; Karen Sherwood; Paul Keown; Ekkehard Schütz; Julia Beck; Johannes Stegbauer; Lars Christian Rump; Philip D Walson
Journal:  Nat Rev Nephrol       Date:  2021-05-24       Impact factor: 28.314

Review 2.  Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA).

Authors:  Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri
Journal:  Mol Diagn Ther       Date:  2019-06       Impact factor: 4.074

3.  Changes in plasma hydroxyproline and plasma cell-free DNA concentrations after higher- versus lower-intensity eccentric cycling.

Authors:  Georgios Mavropalias; Leslie Calapre; Michael Morici; Tomoko Koeda; Wayne C K Poon; Oliver R Barley; Elin Gray; Anthony J Blazevich; Kazunori Nosaka
Journal:  Eur J Appl Physiol       Date:  2021-01-13       Impact factor: 3.078

4.  Mutation detection using plasma circulating tumor DNA (ctDNA) in a cohort of asymptomatic adults at increased risk for cancer.

Authors:  Anja Kammesheidt; Theresa R Tonozzi; Stephen W Lim; Glenn D Braunstein
Journal:  Int J Mol Epidemiol Genet       Date:  2018-02-05

Review 5.  Metabolic Communication and Healthy Aging: Where Should We Focus Our Energy?

Authors:  Hannah J Smith; Arpit Sharma; William B Mair
Journal:  Dev Cell       Date:  2020-07-02       Impact factor: 12.270

Review 6.  Liquid biopsies come of age: towards implementation of circulating tumour DNA.

Authors:  Jonathan C M Wan; Charles Massie; Javier Garcia-Corbacho; Florent Mouliere; James D Brenton; Carlos Caldas; Simon Pacey; Richard Baird; Nitzan Rosenfeld
Journal:  Nat Rev Cancer       Date:  2017-02-24       Impact factor: 60.716

Review 7.  Improving Cancer Detection and Treatment with Liquid Biopsies and ptDNA.

Authors:  Michael D Kessler; Nisha R Pawar; Stuart S Martin; Toni M Antalis; Timothy D O'Connor
Journal:  Trends Cancer       Date:  2018-08-01

8.  Sex Bias in Cohorts Included in Sports Medicine Research.

Authors:  Amanda D Hagstrom; Nicole Yuwono; Kristina Warton; Caroline E Ford
Journal:  Sports Med       Date:  2021-01-05       Impact factor: 11.136

Review 9.  Role of Circulating Tumor DNA in Hematological Malignancy.

Authors:  Miho Ogawa; Kazuaki Yokoyama; Seiya Imoto; Arinobu Tojo
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

10.  Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients.

Authors:  Dana W Y Tsui; Michael L Cheng; Maha Shady; Julie L Yang; Dennis Stephens; Helen Won; Preethi Srinivasan; Kety Huberman; Fanli Meng; Xiaohong Jing; Juber Patel; Maysun Hasan; Ian Johnson; Erika Gedvilaite; Brian Houck-Loomis; Nicholas D Socci; S Duygu Selcuklu; Venkatraman E Seshan; Hongxin Zhang; Debyani Chakravarty; Ahmet Zehir; Ryma Benayed; Maria Arcila; Marc Ladanyi; Samuel A Funt; Darren R Feldman; Bob T Li; Pedram Razavi; Jonathan Rosenberg; Dean Bajorin; Gopa Iyer; Wassim Abida; Howard I Scher; Dana Rathkopf; Agnes Viale; Michael F Berger; David B Solit
Journal:  Genome Med       Date:  2021-05-31       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.